Immunovia

activeseries-c-plus
series-c-plus
Stage
2007
Founded
1
Investors

About

Immunovia AB develops and commercializes blood-based diagnostic tests for early detection of pancreatic cancer, focusing on identifying proteins and antibodies indicating cancer in high-risk individuals.

Explore Immunovia's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.